US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
EP1478406B1
(fr)
|
2002-02-27 |
2011-01-05 |
PharmaIN Corporation |
Compositions pour l'administration de substances therapeutiques et analogues, et procedes de fabrication et d'utilisation desdites compositions
|
ES2420581T3
(es)
|
2003-03-14 |
2013-08-26 |
Biogenerix Gmbh |
Polímeros solubles en agua ramificados y sus conjugados
|
BRPI0407936A
(pt)
|
2003-03-19 |
2006-02-21 |
Lilly Co Eli |
composto de glp-1 peguilado, método de estimular o receptor de glp-1 em um indivìduo, e, uso de composto glp-1 peguilado
|
EP1608680A2
(fr)
*
|
2003-03-24 |
2005-12-28 |
Novo Nordisk A/S |
Derives de glp-2
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
EP1615945B1
(fr)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes
|
WO2004103275A2
(fr)
|
2003-05-09 |
2004-12-02 |
Neose Technologies, Inc. |
Compositions et procedes pour preparer des mutants de glycosylation de l'hormone de croissance humaine
|
US9005625B2
(en)
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
ATE461217T1
(de)
*
|
2003-12-18 |
2010-04-15 |
Novo Nordisk As |
Glp-1-verbindungen
|
JP5743368B2
(ja)
|
2004-01-08 |
2015-07-01 |
ラショファーム ゲーエムベーハー |
ペプチドのo結合型グリコシル化
|
EP1768686A4
(fr)
*
|
2004-06-12 |
2007-11-14 |
Bayer Pharmaceuticals Corp |
Pegylation d'agonistes vis-a-vis du recepteur 2 (vpac2) de peptide intestinal vaso-actif (vip)/peptide d'activation d'adenylate cyclase pituitaire (pacap) et procedes d'utilisation
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
EP1799249A2
(fr)
|
2004-09-10 |
2007-06-27 |
Neose Technologies, Inc. |
Interferon alpha glycopegyle
|
US20080176790A1
(en)
|
2004-10-29 |
2008-07-24 |
Defrees Shawn |
Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
|
US9029331B2
(en)
|
2005-01-10 |
2015-05-12 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
US8716221B2
(en)
|
2005-01-14 |
2014-05-06 |
Wuxi Grandchamp Pharmaceutical Technology Co., Ltd. |
Modified exendins and uses thereof
|
CA2603630C
(fr)
|
2005-01-14 |
2015-06-09 |
Wuxi Grandchamp Pharmaceutical Technology Co., Ltd. |
Exendines modifiees et utilisations correspondantes
|
US20070154992A1
(en)
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
WO2006121860A2
(fr)
*
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Agonistes vis-a-vis du recepteur peptidique de type glucagon 1 (glp-1) et procedes pharmacologiques d'utilisation
|
JP5216580B2
(ja)
|
2005-05-25 |
2013-06-19 |
ノヴォ ノルディスク アー/エス |
グリコペグ化第ix因子
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
ES2336575T3
(es)
|
2005-09-22 |
2010-04-14 |
Biocompatibles Uk Limited |
Polipeptidos de fusion glp-1 (peptido-1 similar al glucagon) con resistencia aumentada a la peptidasa.
|
US8759290B2
(en)
*
|
2005-10-18 |
2014-06-24 |
Biocon Limited |
Oral glucagon-like peptide conjugates for metabolic diseases
|
WO2007049695A1
(fr)
*
|
2005-10-26 |
2007-05-03 |
Chugai Seiyaku Kabushiki Kaisha |
Analogue de glp-1 agglutinable et composition pharmaceutique a liberation prolongee
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
EP1959986B1
(fr)
*
|
2005-11-07 |
2014-07-23 |
Indiana University Research and Technology Corporation |
Analogues de glucagon a solubilite et a stabilite physiologiques ameliorees
|
ES2390286T3
(es)
|
2005-12-16 |
2012-11-08 |
Nektar Therapeutics |
Conjugados poliméricos de GLP-1
|
EP3449946A3
(fr)
|
2005-12-19 |
2020-11-04 |
PharmaIN Corporation |
Compositions de support à noyau hydrophobe pour l'administration d'agents thérapeutiques, procédés de fabrication et d'utilisation de celles-ci
|
US8288339B2
(en)
|
2006-04-20 |
2012-10-16 |
Amgen Inc. |
GLP-1 compounds
|
DE602006009631D1
(de)
*
|
2006-05-10 |
2009-11-19 |
Biocompatibles Uk Ltd |
GLP-1 Peptide enthaltende kugelförmige Mikrokapseln, deren Produktion und deren Verwendung
|
KR100886783B1
(ko)
|
2006-06-12 |
2009-03-04 |
성균관대학교산학협력단 |
N-말단이 수식된 peg-trail 결합체, 이의 제조방법 및 이의 용도
|
EP2452683A3
(fr)
|
2006-06-26 |
2012-08-22 |
Amgen Inc. |
Procédés pour le traitement de l'athérosclérose
|
US20080242607A1
(en)
|
2006-07-21 |
2008-10-02 |
Neose Technologies, Inc. |
Glycosylation of peptides via o-linked glycosylation sequences
|
US20100075375A1
(en)
|
2006-10-03 |
2010-03-25 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
CN101125207B
(zh)
*
|
2006-11-14 |
2012-09-05 |
上海华谊生物技术有限公司 |
带有聚乙二醇基团的艾塞丁或其类似物及其制剂和用途
|
SG177953A1
(en)
|
2007-01-05 |
2012-02-28 |
Univ Indiana Res & Tech Corp |
Glucagon analogs exhibiting enhanced solubility in physiological ph buffers
|
MX2009008241A
(es)
|
2007-02-15 |
2009-10-08 |
Univ Indiana Res & Tech Corp |
Co-agonistas de receptor de glucagon/glp-1.
|
KR20100016160A
(ko)
|
2007-04-03 |
2010-02-12 |
바이오제너릭스 에이지 |
글리코페길화 g―csf를 이용하는 치료 방법
|
GB2448895A
(en)
*
|
2007-05-01 |
2008-11-05 |
Activotec Spp Ltd |
GLP-1 like compounds and uses thereof
|
MX2009013259A
(es)
|
2007-06-12 |
2010-01-25 |
Novo Nordisk As |
Proceso mejorado para la produccion de azucares de nucleotidos.
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
JP5669582B2
(ja)
|
2007-10-30 |
2015-02-12 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
グルカゴンアンタゴニスト
|
JP5771005B2
(ja)
|
2007-10-30 |
2015-08-26 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
グルカゴンアンタゴニスト及びglp−1アゴニスト活性を示す化合物
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
US20130189239A1
(en)
|
2008-02-27 |
2013-07-25 |
Novo Nordisk A/S |
Conjugated Factor VIII Molecules
|
EA019203B9
(ru)
|
2008-06-17 |
2014-03-31 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Коагонисты глюкагонового рецептора/glp-1-рецептора
|
JP6108659B2
(ja)
|
2008-06-17 |
2017-04-05 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
代謝疾患および肥満の治療のためのgipに基づいた混合アゴニスト
|
CN102264228A
(zh)
|
2008-10-22 |
2011-11-30 |
默沙东公司 |
用于抗糖尿病药的新的环状苯并咪唑衍生物
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
AR074811A1
(es)
|
2008-12-19 |
2011-02-16 |
Univ Indiana Res & Tech Corp |
Profarmaco de peptido de la superfamilia de glucagon basados en amida
|
US9382525B2
(en)
*
|
2009-03-26 |
2016-07-05 |
The Hong Kong Polytechnic University |
Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
|
EP2411040B1
(fr)
*
|
2009-03-26 |
2015-09-23 |
The Hong Kong Polytechnic University |
Pégylation dirigée contre un site d'arginases et son utilisation en tant qu'agents anticancéreux et antiviraux
|
CN102459325B
(zh)
|
2009-06-16 |
2015-03-25 |
印第安纳大学科技研究有限公司 |
胃抑胜肽受体活化的胰高血糖素化合物
|
ES2534191T3
(es)
*
|
2009-11-13 |
2015-04-20 |
Sanofi-Aventis Deutschland Gmbh |
Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
|
EP2512503A4
(fr)
|
2009-12-18 |
2013-08-21 |
Univ Indiana Res & Tech Corp |
Co-agonistes du récepteur du glucagon/glp-i
|
EP2359843A1
(fr)
*
|
2010-01-21 |
2011-08-24 |
Sanofi |
Composition pharmaceutique pour le traitement d'un syndrome métabolique
|
KR20120123443A
(ko)
|
2010-01-27 |
2012-11-08 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
대사 장애 및 비만 치료용 글루카곤 길항제-gip 항진제 콘쥬게이트
|
WO2011106273A1
(fr)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Nouveaux dérivés benzimidazole cycliques utiles comme agents antidiabétiques
|
US9127088B2
(en)
|
2010-05-13 |
2015-09-08 |
Indiana University Research And Technology Corporation |
Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
|
CN103179976A
(zh)
|
2010-05-13 |
2013-06-26 |
印第安纳大学研究及科技有限公司 |
呈现g蛋白偶联受体活性的胰高血糖素超家族肽
|
KR20130102470A
(ko)
|
2010-06-24 |
2013-09-17 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
아미드계 글루카곤 슈퍼패밀리 펩티드 프로드러그
|
US20130137645A1
(en)
*
|
2010-07-19 |
2013-05-30 |
Mary S. Rosendahl |
Modified peptides and proteins
|
ES2713952T3
(es)
|
2010-12-22 |
2019-05-24 |
Univ Indiana Res & Tech Corp |
Análogos de glucagón que muestran actividad de receptor de GIP
|
CA2826649C
(fr)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Nouveaux derives d'azabenzimidazole cyclique utiles en tant qu'agents antidiabetiques
|
BR112013032717A2
(pt)
|
2011-06-22 |
2017-01-24 |
Univ Indiana Res & Tech Corp |
coagonistas do receptor de glucagon/glp-1
|
RS56173B1
(sr)
|
2011-06-22 |
2017-11-30 |
Univ Indiana Res & Tech Corp |
Koagonisti receptora za glukagon/glp-1 receptora
|
KR101357117B1
(ko)
|
2011-06-28 |
2014-02-06 |
비앤엘델리팜 주식회사 |
폴리에틸렌글라이콜 또는 이의 유도체로 페길화된 엑센딘-4 유사체, 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물
|
EP2742061A4
(fr)
*
|
2011-08-08 |
2015-05-27 |
Two To Biotech Ltd |
Nouveaux peptides, compositions les comprenant et leurs utilisations dans des méthodes pour le traitement de troubles métaboliques, cardiaques et immunitaires
|
CN103957927B
(zh)
|
2011-11-17 |
2016-11-09 |
印第安纳大学研究及科技有限公司 |
呈现糖皮质激素受体活性的胰高血糖素超家族肽
|
EP2864351B1
(fr)
|
2012-06-21 |
2016-08-10 |
Indiana University Research and Technology Corporation |
Analogues du glucagon présentant une activité sur le récepteur du gip
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
TWI617574B
(zh)
*
|
2012-12-11 |
2018-03-11 |
梅迪繆思有限公司 |
用於治療肥胖之升糖素與glp-1共促效劑
|
BR112015019836A2
(pt)
|
2013-02-22 |
2017-07-18 |
Merck Sharp & Dohme |
composto, composição farmacêutica, e, uso de um composto
|
US9714277B2
(en)
*
|
2013-03-14 |
2017-07-25 |
Medimmune Limited |
Pegylated glucagon and GLP-1 co-agonists for the treatment of obesity
|
US9650375B2
(en)
|
2013-03-14 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as anti-diabetic agents
|
WO2015051496A1
(fr)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Composés tricycliques antidiabétiques
|
WO2015081891A1
(fr)
|
2013-12-06 |
2015-06-11 |
Baikang (Suzhou) Co., Ltd |
Pro-fragments bioréversibles pour médicaments contenant de l'azote et de l'hydroxyle
|
US11299528B2
(en)
|
2014-03-11 |
2022-04-12 |
D&D Pharmatech Inc. |
Long acting TRAIL receptor agonists for treatment of autoimmune diseases
|
US20160151511A1
(en)
|
2014-12-02 |
2016-06-02 |
Antriabio, Inc. |
Proteins and protein conjugates with increased hydrophobicity
|
RU2730848C2
(ru)
|
2015-06-04 |
2020-08-26 |
Резолют, Инк. |
Способы пэгилирования по аминогруппе для получения сайт-специфичных конъюгатов белков
|
TWI726889B
(zh)
|
2015-06-10 |
2021-05-11 |
英商梅迪繆思有限公司 |
蛋白酶抗性之脂化肽
|
CN108601819B
(zh)
|
2015-12-17 |
2022-03-15 |
约翰霍普金斯大学 |
用死亡受体激动剂改善系统性硬化症
|
WO2017112889A1
(fr)
|
2015-12-23 |
2017-06-29 |
The Johns Hopkins University |
Agoniste de glp-1r à action prolongée pour la thérapie de troubles neurologiques et neurodégénératifs
|
CN109414469A
(zh)
*
|
2016-03-16 |
2019-03-01 |
普罗林科斯有限责任公司 |
艾塞那肽类似物的缓释偶联物
|
KR102508650B1
(ko)
|
2016-04-07 |
2023-03-13 |
더 존스 홉킨스 유니버시티 |
사멸 수용체 작용제로써 췌장암 및 통증을 치료하기 위한 조성물 및 방법
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
EP3558298A4
(fr)
|
2016-12-20 |
2020-08-05 |
Merck Sharp & Dohme Corp. |
Composés de spirochromane antidiabétiques
|
KR102193211B1
(ko)
*
|
2019-11-27 |
2020-12-18 |
(주)디앤디파마텍 |
비오틴 모이어티가 결합된 폴리펩티드 및 이를 포함하는 경구 투여용 약학적 조성물
|